HSP90AA1 and hepatocellular carcinoma: In addition, a further subgroup analysis showed that the plasma HSP90α have a limited diagnosis efficiency for early HCC patients with tumors of less than 2 cm or those at an early BCLC stage (ie. BCLC-A).